World Sight Day renews hope for eye, vision care for all people

Article

Participate in the World Sight Day Challenge to help prevent blindness.

 

Golden, CO-Optometry Giving Sight (OGS) is urging everyone in the optical community and anyone who values good vision to take part in the World Sight Day Challenge, September 1 through World Sight Day-October 10.

The World Sight Day Challenge is the largest annual global fundraising campaign to address avoidable blindness caused by uncorrected refractive error. This year, OGS is applying the concept of “people power,” using a colorful new logo to give a fresh look and feel to the campaign.

Participating is easy. Simply make a monthly or annual donation on or before World Sight Day, October 10. Optometry practices and ophthalmic businesses can also be creative and engage patients, customers, and staff with fundraising events throughout the challenge period.

“Preventable blindness is a solvable problem-and the World Sight Day Challenge is a great way for everyone to make a meaningful contribution and help to provide eye and vision care for all people,” said Clive Miller, CEO of OGS.

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.